Role of thromboelastography in evaluating other anticoagulant agents: warfarin and heparin-dihydroergotamine.
Traverso
C I
CI
Department of Surgery and Related Specialties, University of Granada Hospital, Spain.
Arcelus
J I
JI
Caprini
J A
JA
D000328:Adult; D000368:Aged; D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects*; D002986:Clinical Trials as Topic; D004087:Dihydroergotamine / Q000008:administration & dosage / Q000494:pharmacology*; D004338:Drug Combinations; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000379:methods*; D011183:Postoperative Complications / Q000097:blood / Q000517:prevention & control; D011517:Prothrombin Time; D011817:Rabbits; D012015:Reference Standards; D013916:Thrombelastography; D013923:Thromboembolism / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D014859:Warfarin / Q000008:administration & dosage / Q000494:pharmacology*
D000925:Anticoagulants; D004338:Drug Combinations; D006495:Heparin, Low-Molecular-Weight; C031388:heparin-dihydergot; D004087:Dihydroergotamine; D014859:Warfarin